Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Stem Cells. 2017 Dec;35(12):2351–2365. doi: 10.1002/stem.2720

Figure 2. Tregs-CM promotes tumorigenisis of EO771 cells in vivo.

Figure 2

A Schematic diagram of the experimental procedure. C57BL/6 mice were inoculated with different amounts of Tregs-CM pretreated EO771 cells mixed with Tregs (Tregs-CM pretreated EO771/Tregs, at the cell number ratio of 20:1), the control-medium-pretreated EO771 cells were inoculated as the control. Tumor free survival curve, analyzed by Log-rank test (B), harvested tumor xenografts at the 21th day post graft (C) and tumor growth curves (D) assays showing that Tregs CM increased tumorigenicity of EO771 cells when compared with control. n = 6 mice for each 200K- and 50K-cells inoculation group. n = 7 mice for each 10K-cells inoculation group. *, p < .05; **, p < .01. Abbreviations: EGFP, enhanced green fluorescent protein; Tregs CM, Tregs conditioned medium.